Science

Thought Leadership

Providing Thought Leadership is our commitment to improving the science of laboratory testing for the insurance industry. Providing our clients a competitive advantage is our unwavering commitment. As Thought Leaders, we drive perpetual discovery to inspire change. We will continue to be at the forefront of questioning the status quo, while applying valid science and research analysis to improve risk selection—that's the result of Thought Leadership.

CRL's published Research & Development:

A1C non smoking

A1c-five year follow up

Liver (GGT, AST, ALT)

Non-cig tobacco

CRL Bulletins:

Using CRL Risk-based Laboratory Bulletins to Improve Risk Selection

Cotinine Billirubin Liver Enzymes Fructosamine and HbA1c

Michael W. Fulks, MD

Consulting Medical Director

Vera F. Dolan, MSPH

Consultant

Clinical Reference Laboratory

Robert L. Stout, Ph.D.

President

Dr. Stout has been with CRL since 1983 and is responsible for day to day directorship of CRL's college of American Pathologists (CAP)-Accredited reference laboratory.

Dr. Stout holds U.S. Patents in science, including one for immunoassay method and apparatus development and one for methods of determining chronic Hepatitis C infection. He is the author of numerous research and review articles and is a regular presenter at scientific meetings and conferences, recently presenting "Laboratory Tests: Clinical vs. Insurance Medicine" at ICLAM International Committee for Life, Disability & Health Assurance Medicine in Italy.

Dr. Stout holds a B.S. in Biochemistry from California State University and a Ph.D. in Biological Chemistry from U.C.L.A. School of Medicine.

Patents

1. Treatment of Mammals with Natural Killer Activating Factor

2. Catalyzed Colorimetric and Fluorometric Substrates for

Peroxidase Enzyme Determinations

3. Biologic and Method of Preparing the Same

4. Immunoassay Method and Apparatus

5. Method for the Determination of Antigens and Antibodies Using

Site-Deactivating Media

6. Method of Increasing Natural Killer Cell Population of Cancer

Patients

7. Capillary Electrophoresis of Transferrin Glycoforms

8. Hepatitis C Screening Assay and Methods of Use Thereof

9. Methods for Assessment of Cardiovascular Disease Risk

To register for our newsletter: Click Here

CRL is a registered trademark of Clinical Reference Laboratory, Inc.